Sarepta Therapeutics, Inc.

Historical 13F Holders

Symbol
SRPT
CUSIP
803607100
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 138 7.00 M $118 M
2025 Q1 475 87.4 M $5.53 B
2024 Q4 507 89.3 M $10.7 B
2024 Q3 506 89.6 M $11.0 B
2024 Q2 543 93.5 M $14.8 B
2024 Q1 460 86.9 M $11.3 B
2023 Q4 449 84.9 M $8.20 B
2023 Q3 460 83.6 M $10.1 B
2023 Q2 451 82.3 M $9.43 B
2023 Q1 474 81.8 M $11.3 B
2022 Q4 457 82.0 M $10.6 B
2022 Q3 416 84.8 M $9.38 B
2022 Q2 366 73.5 M $5.51 B
2022 Q1 359 73.3 M $5.73 B
2021 Q4 390 72.3 M $6.51 B
2021 Q3 344 65.8 M $6.08 B
2021 Q2 364 64.9 M $5.05 B
2021 Q1 403 66.5 M $4.96 B
2020 Q4 523 72.1 M $12.3 B
2020 Q3 462 72.2 M $10.1 B
2020 Q2 457 74.2 M $11.9 B
2020 Q1 416 74.7 M $7.31 B
2019 Q4 445 74.5 M $9.61 B
2019 Q3 396 75.4 M $5.63 B
2019 Q2 431 73.3 M $11.1 B
2019 Q1 420 71.3 M $8.51 B
2018 Q4 381 69.4 M $7.58 B
2018 Q3 389 63.0 M $10.2 B
2018 Q2 361 60.9 M $8.05 B
2018 Q1 303 57.8 M $4.28 B
2017 Q4 296 55.3 M $3.07 B
2017 Q3 284 53.7 M $2.44 B
2017 Q2 224 42.7 M $1.44 B
2017 Q1 214 41.0 M $1.21 B
2016 Q4 226 39.8 M $1.09 B
2016 Q3 247 42.4 M $2.61 B
2016 Q2 206 34.6 M $661 M
2016 Q1 166 35.1 M $686 M
2015 Q4 191 28.6 M $1.10 B
2015 Q3 175 30.6 M $982 M
2015 Q2 154 26.7 M $812 M
2015 Q1 128 24.2 M $321 M
2014 Q4 145 25.0 M $363 M
2014 Q3 145 26.0 M $549 M
2014 Q2 148 29.9 M $892 M
2014 Q1 139 26.6 M $639 M